PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Biologists discover solution to problem limiting development of human stem cell therapies

2014-01-02
(Press-News.org) Contact information: Kim McDonald
kmcdonald@ucsd.edu
858-534-7572
University of California - San Diego
Biologists discover solution to problem limiting development of human stem cell therapies Biologists at UC San Diego have discovered an effective strategy that could prevent the human immune system from rejecting the grafts derived from human embryonic stem cells, a major problem now limiting the development of human stem cell therapies. Their discovery may also provide scientists with a better understanding of how tumors evade the human immune system when they spread throughout the body. The achievement, published in a paper in this week's early online edition of the journal Cell Stem Cell by a collaboration that included scientists from China, was enabled by the development of "humanized" laboratory mice that contained a functional human immune system capable of mounting a vigorous immune rejection of foreign cells derived from human embryonic stem cells. Because human embryonic stem cells are different from our own body's cells, or "allogenic," a normally functioning human immune system will attack these foreign cells. One way to reduce the body's "allogenic immune response" is to suppress the immune system with immunosuppressant drugs. "For organ transplantation to save patients with terminal diseases that has been quite successful," says Yang Xu, a professor of biology who headed the team of researchers that included Ananda Goldrath, an associate biology professor at UC San Diego. "But for stem cell therapies, the long term use of toxic immunosuppressant drugs for patients who are being treated for chronic diseases like Parkinson's disease or diabetes pose serious health problems." Researchers had long been searching for a human immunity relevant model that would allow them to develop strategies to implant allogenic cells derived from embryonic stem cells safely. "The problem is that we only had data from mouse immune system and those are not usually translatable in humans, because human and mouse immune systems are quite different," explains Xu. "So what we decided to do was to optimize the humanized mouse that carries a functional human immune system." To do that, the biologists took immune deficient laboratory mice and grafted into their bodies human fetal thymus tissues and hematopoietic stem cells derived from fetal liver of the same human donor. "That reconstituted in these mice a normally functioning human immune system that effectively rejects cells derived human embryonic stem cells," says Xu. With these "humanized" mouse models, the biologists then tested a variety of immune suppressing molecules alone or in combination and discovered one combination that worked perfectly to protect cells derived from human embryonic stem cells from immune rejection. That combination was CTLA4-lg, an FDA-approved drug for treating rheumatoid arthritis that suppresses T-cells responsible for immune rejection, and a protein called PD-L1 known to be important for inducing immune tolerance in tumors. The researchers discovered that the combination of these two molecules allowed the allogeneic cells to survive in humanized mice without triggering an immune rejection. "If we express both molecules in cells derived from human embryonic cells, we can protect these cells from the allogenic immune rejection," says Xu. "If you have only one such molecule expressed, there is absolutely no impact. We still don't know exactly how these pathways work together to suppress immune rejection, but now we've got an ideal system to study this." He and his team of researchers also believe their discovery and the development of their humanized mouse models may offer the much needed tools to develop ways to activate immune response to tumors, because these molecules are known to be important in allowing tumors to evade the human immune system. "You're dealing with the same exact pathways that protect tumors from our immune system," says Xu. "If we can develop strategies to disrupt or silence these pathways in tumors, we might be able to activate immunity to tumors. The humanized mouse system is really a powerful model with which to study human tumor immunity." ### Other researchers involved in the study, besides Xu and Goldrath, were Zhili Rong, Meiyan Wang, Martin Stradner and Huijuan Kong of UC San Diego; Zheng Hu, Huanfa Yi and Yong-Guang Yang of China's Jilin University; Shengyun Zhu and Xuemei Fu of Shenzhen Children's Hospital in China. The study was financed by grants from the California Institute for Regenerative Medicine, the National Institutes of Health (AI-064569 and AI-045897), the Chinese Ministry of Science and Technology, and the Natural Sciences Foundation of China.


ELSE PRESS RELEASES FROM THIS DATE:

Study on pregnancy and alcohol fails to take psychological factors into account

2014-01-02
Study on pregnancy and alcohol fails to take psychological factors into account "It is OK to drink a little bit of alcohol during pregnancy" or "a pregnant woman should not touch alcohol at all during her pregnancy". These statements represent the ...

Brain training works, but just for the practiced task, say Oregon researchers

2014-01-02
Brain training works, but just for the practiced task, say Oregon researchers Revealing pattern of changes detected in brain using MRI as 'trained' subjects show improved self-control EUGENE, Ore. -- Search for "brain training" on the Web. You'll find online exercises, ...

Mass spectrometer detection of 10 protein spots after acute high-altitude HBI

2014-01-02
Mass spectrometer detection of 10 protein spots after acute high-altitude HBI Hypobaric hypoxia can cause severe brain damage and mitochondrial dysfunction, and is involved in hypoxic brain injury. Dr. Jianyu Li and colleagues from Logistics College of Chinese ...

Differences in brain structure in patients with distinct sites of chronic pain

2014-01-02
Differences in brain structure in patients with distinct sites of chronic pain Accumulating evidence indicates that chronic pain of different etiologies is often associated with distinct gray matter volume reductions in multiple brain regions associated with ...

Diffusion tensor MRI-based tractography in evaluation of nerve root function

2014-01-02
Diffusion tensor MRI-based tractography in evaluation of nerve root function If bulging or protruding intervertebral discs occupies the intervertebral foramen, and nerve roots are compressed. The cross-sectional area of nerve root fibers is reduced, fiber bundles ...

Under pressure

2014-01-02
Under pressure A harness for guide dogs must suit both dog and owner Guide dogs lend their eyes to blind people, enabling them to find their way around in an environment they cannot see. Guide dogs require about four ...

Scientists uncover hidden river of rubbish threatening to devastate wildlife

2014-01-02
Scientists uncover hidden river of rubbish threatening to devastate wildlife Thousands of pieces of plastic have been discovered, submerged along the river bed of the upper Thames Estuary by scientists at Royal Holloway, University of London and ...

Scientists explain age-related obesity: Brown fat fails

2014-01-02
Scientists explain age-related obesity: Brown fat fails New research in The FASEB Journal suggests that platelet-activating factor receptors cause increased adiposity and weight gain, and regulating these receptors could lead to ...

Money talks when ancient Antioch meets Google Earth

2014-01-02
Money talks when ancient Antioch meets Google Earth There's a map of an ancient Syrian trade route that shows how one city's political sway extended farther than once thought. This map isn't a time-worn and mysterious etching on a stone tablet. Turns out it's ...

Want a good night's sleep in the new year? Quit smoking

2014-01-02
Want a good night's sleep in the new year? Quit smoking New research in The FASEB Journal identifies the mechanism by which tobacco smoke affects the expression of clock genes in the lung and resets levels of locomotor activity in ...

LAST 30 PRESS RELEASES:

Prevalence, determinants, and time trends of cardiovascular health in the WHO African region

New study finds that, after a heart attack, women have worse prognosis when treated with beta-blockers

CNIC-led REBOOT clinical trial challenges 40-year-old standard of care for heart attack patients

Systolic blood pressure and microaxial flow pump–associated survival in infarct-related cardiogenic shock

Beta blockers, the standard treatment after a heart attack, may offer no benefit for heart attack patients and women can have worse outcomes

High Mountain Asia’s shrinking glaciers linked to monsoon changes

All DRII-ed up: How do plants recover after drought?

Research on stigma says to just ‘shake it off’

Scientists track lightning “pollution” in real time using NASA satellite

Millions of women rely on contraceptives, but new Rice study shows they may do more than just prevent pregnancy

Hot days make for icy weather, Philippine study finds

Roxana Mehran, MD, receives the most prestigious award given by the European Society of Cardiology

World's first clinical trial showing lubiprostone aids kidney function

Capturing language change through the genes

Public trust in elections increases with clear facts

Thawing permafrost raised carbon dioxide levels after the last ice age

New DNA test reveals plants’ hidden climate role

Retinitis pigmentosa mouse models reflect pathobiology of human RP59

Cell’s ‘antenna’ could be key to curing diseases

Tiny ocean partnership between algae and bacteria reveals secrets of evolution

Scientists uncover cellular “toolkit” to reprogram immune cells for cancer therapy

Blocking protein control pathway slows rhabdomyosarcoma growth in mice

2026 Hertz Fellowship Application Now Open

The gut immune system is altered in mouse model of Alzheimer’s, providing a new target for therapeutics

ADHD drugs are being prescribed too quickly to preschoolers

UCLA scientists develop off-the-shelf immunotherapy for metastatic kidney cancer

Extreme heat linked to spike in domestic violence calls in New Orleans, study finds

Mount Sinai-Duke University study identifies DNA variants that increase testosterone production in PCOS patients

Physiology-guided complete revascularization in older patients with myocardial infarction

Metals and sulfate in air pollution mixture may contribute most to asthma hospitalizations

[Press-News.org] Biologists discover solution to problem limiting development of human stem cell therapies